Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma

Clinical Endocrinology

Volumn 48, Issue 2, 1998, Pages 195-200

  Pomares, F J ^a   Canas R ^a   Rodriguez, J M ^a   Hernandez, A M ^a   Parrilla, P ^a   Tebar, F J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALECTOMY; ADULT; ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FAMILIAL CANCER; HUMAN; HYPERTENSION; ONSET AGE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIPPLE SYNDROME; SPAIN;

EID: 0031889547     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.3751208.x     Document Type: Article

References (25)

1. Anderson, R.J. & Lynch, H.T. (1997) Familial neuroendocrine tumors as a model of hereditary cancer. Current Opinion in Oncology, 9, 45-54.
2. Bravo, E.L. & Gifford, R.W. (1984) Phaechromocytoma: diagnosis. localization and management. New England Journal of Medicine. 30, 1682-1686.
3. Bravo, E.L. & Gifford, R.W. (1993) Pheochromocytoma. Endocrinology and Metabolism Clinics of North America. 22, 329-341.
4. Casanova, S., Rosenberg-Bourgin, M., Farkas, D., Calmettes, C., Feingold, N., Heshmati, H.M., Cohen, R., Conte-Devoix, B., Guillausseau, P.J., Houdent, C., Bigorgne, J.C., Boiteau, V., Caron, J. & Modigliani, E. (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clinical Endocrinology, 38, 531-537.
5. Clesham, G.J., Kennedy, A., Lavender, J.P., Dollery, C.T. & Wilkins, M.R. (1993) Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma. Journal of Human Hypertension, 7, 353-356.
6. Ein, S.H., Weitzman, S., Thorner, P., Seagram, G. & Filler, R.M. (1994) Pediatric malignant pheochromocytoma. Journal of Pediatric Surgery, 29, 1197-1201.
7. Eng, C. (1996) The RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschprung's disease. New England Journal of Medicine, 335, 943-951.
8. Evans, D.B., Lee, J.E., Merrell, R.C. & Hickey, R.C. (1994) Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management. Endocrinology and Metabolism Clinics of North America, 23, 167-176.
9. Fonseca, V. & Bouloux, P.M. (1993) Phaeochromocytoma and paraganglioma. Baillière's Clinical Endocrinology and Metabolism, 7, 509-544.
10. Graham, P.E., Smythe, G.A., Edwards, G.A. & Lazarus, L. (1993) Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Annals of Clinical Biochemistry, 30, 129-134.
11. Griffing, G. (1994) A-I-D-S: the new endocrine epidemic (editorial). Journal of Clinical Endocrinology and Metabolism, 79, 1530-1531.
12. Howe, J.R., Norton, J.A. & Wells, S.A. (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery, 114, 1070-1077.
13. Lairmore, T.C., Ball, D.W., Baylin, S.B. & Wells, S.A. (1993) Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Annals of Surgery, 217, 595-603.
14. Lenders, J., Keiser, H., Goldstein, D., Willemsen, J., Friberg, P., Jacobs, M.C., Kloppenborg, P., Thien, T. & Eisenhofer, G. (1995) Plasma metanephrines in the diagnosis of pheochromocytoma. Annals of Internal Medicine, 123, 101-109.
15. Lips, K.J.M., Van der Sluys, J., Struyvenberg, A., Alleman, A., Leo, J.R., Wittebol, P., Minder, W.H., Kooiker, C.J., Geerdink, R.A., Van Waes, P.F.G.M. & Hackeng, W.H.L. (1981) Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia type 2A (Sipple's syndrome). American Journal of Medicine, 70, 1051-1060.
16. Manger, W.M. & Gifford, R.W. (1993) Phaeochromocytoma: current diagnosis and management. Cleveland Clinic Journal of Medicine, 60, 365-378.
17. Modigliani, E., Vasen, H.M., Raue, K., Dralle, H., Frilling, A., Gheri, R.G., Brandi, M.L., Limbert, E., Niederle, B., Forgas, L., Rosenberg-Bourgain, M., Calmettes, C. & The Euromen Study Group (1995) Pheochromocytoma in multiple endocrine neoplasia type 2: European study. Journal of Internal Medicine, 238, 363-367.
18. Orchard, T., Grant, C.S., van Heerden, J.A. & Weaver, A. (1993) Pheochromocytoma - continuing evolution of surgical therapy. Surgery, 114, 1153-1159.
19. Peaston, R.T. & Lai, L.C. (1993) Biochemical detection of phaeochromocytoma: should we still he measuring urinary HMMA? Journal of Clinical Pathology, 46, 734-737.
20. Raue, F., Frank-Raue, K. & Grauer, A. (1994) Multiple endocrine neoplasia type 2. Clinical features and screening. Endocrinology and Metabolism Clinics of North America, 23, 137-156.
21. Sakahara, H., Endo, K., Saga, T., Hosono, M., Koboyasi, H. & Honishi, J. (1994) 131 1-metaiodobenzylguanidine therapy for malignant pheochromocytoma. Annals of Nuclear Medicine, 8, 133-137.
22. Shapiro, B. (1993) Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment. Baillière's Clinical Endocrinology and Metabolism, 7, 491-507.
23. Shapiro, B. & Gross, M.D. (1991) Pheocromocytoma. Critical Care Clinics, 7, 1-21.
24. Sheps, S.G., Jiang, N.S., Klee, G.G. & van Heerden, J.A. (1990) Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clinics Proceedings, 65, 88-95.
25. Werbel, S.S. & Ober, K.P. (1995) Pheochromocytoma: update on diagnosis, localization and management. Medical Clinics of North America, 79, 131-153.